SCHEMBL3464038

SCHEMBL3464038

C=COC(C)Oc1ccc(C(C)(C)c2ccc(OC(C)OC=C)cc2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.33
HPGD P15428 3/20 0.33
TSHR P16473 3/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
TP53 P04637 2/20 0.33
MAPT P10636 2/20 0.33
HIF1A Q16665 2/20 0.33
AR P10275 2/20 0.33
HTT P42858 2/20 0.33
CYP1A2 P05177 1/20 0.33
PPARG P37231 1/20 0.33
ESR1 P03372 1/20 0.33
CYP3A4 P08684 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
HTR6 P50406 1/20 0.33
ESRRG P62508 1/20 0.33
SLC6A3 Q01959 1/20 0.33
ESR2 Q92731 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11789502 0.89 MAPT (0.39) ALDH1A1HPGDTSHRMEN1KMT2A
SCHEMBL1344967 0.87 ALDH1A3 (0.39) ALDH1A1TSHRKMT2ATP53CYP1A2
SCHEMBL3958244 0.81 CYP1A2 (0.39) KMT2AMAPTCYP1A2ESR2GAA
SCHEMBL11788149 0.79 CA1 (0.44) ALDH1A1TSHRTP53CYP1A2ESR1
SCHEMBL9557952 0.79 ALDH1A3 (0.34) ALDH1A3
SCHEMBL2960693 0.79 ACHE (0.38) ALDH1A1TSHRMEN1KMT2AMAPT
SCHEMBL6273128 0.79 HPGD (0.39) ALDH1A1HPGDTSHRMEN1KMT2A
SCHEMBL8755128 0.78 ALDH1A1 (0.36) ALDH1A1HPGDTSHRMEN1KMT2A
SCHEMBL2449735 0.78 ESR2 (0.38) MEN1KMT2AMAPTESR1SLC6A2
SCHEMBL6115215 0.78 ALDH1A3 (0.33) ALDH1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080045618-A1 Low viscosity UV curable ink formulations COLLINS INK CORPORATION 2008-02-21 US claimed
WO-2008002543-A2 LOW VISCOSITY UV CURABLE INK FORMULATIONS HEXION SPECIALTY CHEMICALS INC. (US) 2008-01-03 WO claimed
EP-4565378-B1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2026-05-06 EP disclosed
US-12616995-B2 Methods for producing overt security features exhibiting one or more indicia SICPA HOLDING SA (CH) 2026-05-05 US disclosed
EP-4352175-B1 HYBRID UV-LED RADIATION CURABLE PROTECTIVE VARNISHES FOR SECURITY DOCUMENTS SICPA HOLDING SA (CH) 2026-02-25 EP disclosed
US-20260015799-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2026-01-15 US disclosed
US-12515470-B2 UV-Vis radiation curable security inks SICPA HOLDING SA (CH) 2026-01-06 US disclosed
EP-4433547-B1 METHODS FOR PRODUCING OVERT SECURITY FEATURES EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2025-12-24 EP disclosed
US-12391841-B2 Hybrid UV-LED radiation curable protective varnishes for security documents SICPA HOLDING SA (CH) 2025-08-19 US disclosed
EP-4565378-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA Sicpa Holding SA (CH) 2025-06-11 EP disclosed
US-12311406-B2 Methods for producing optical effect layers comprising magnetic or magnetizable pigment particles and exhibiting one or more indicia SICPA HOLDING SA (CH) 2025-05-27 US disclosed
EP-1243629-B1 Active energy beam curable composition and ink BROTHER IND LTD (JP) 2006-08-23 EP disclosed
US-6852767-B2 Active energy beam curable composition having predetermined acid value or amine value and ink containing the same BROTHER KOGYO KABUSHIKI KAISHA (JP) 2005-02-08 US disclosed
US-20020188033-A1 Active energy beam curable composition and ink BROTHER KOGYO KABUSHIKI KAISHA (JP) 2002-12-12 US disclosed
EP-1243629-A1 Active energy beam curable composition and ink BROTHER KOGYO KABUSHIKI KAISHA (JP) 2002-09-25 EP disclosed
US-4705887-A Aromatic polyvinyl ethers and heat curable molding compositions obtained therefrom GENERAL ELECTRIC COMPANY (US) 1987-11-10 US disclosed
EP-0207893-A2 Image-forming process CIBA-GEIGY AG (CH) 1987-01-07 EP disclosed
US-4518788-A Aromatic polyvinyl ethers and heat curable molding compositions obtained therefrom GENERAL ELECTRIC COMPANY (US) 1985-05-21 US disclosed
US-4388450-A THERMAL CURING CATALYSTS, QUICK-SETTING; GENERAL ELECTRIC COMPANY (US) 1983-06-14 US disclosed
US-3933509-A Photo-polymerizable composition containing an acid salt of an indolinobenzospiropyran FUJI PHOTO FILM CO., LTD. (JA) 1976-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260015799-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA IK, TEX10, INCENP ALDH1A1 1748/4885HPGD 4318/4885TSHR 2447/4885
US-12616995-B2 Methods for producing overt security features exhibiting one or more indicia ATG4B, TPM4, ATG4A ALDH1A1 615/4885HPGD 4265/4885TSHR 416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.